ArticleJournal of enzyme inhibition and medicinal chemistry2022

From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19?

Matteo Pavan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.